Free Clinical Trial Templates | Smartsheet
PDF) A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: Interim analysis
Clinical Trial Services
FAQ | Pharma Instinct
Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials -
Assessing the value of interim analyses in clinical trials - PMLiVE
Challenging Issues in Clinical Trial Design: Part 4 of a 4-Part Series on Statistics for Clinical Trials - ScienceDirect
CLINICAL STUDY REPORTING - Assessing the Value of Interim Analyses in Clinical Trials
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care | Journal of Clinical Oncology
A Guide to Phase 1 Clinical Trial Designs
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials | Nature Communications
The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias | BMC Medical Research Methodology | Full Text
Assessing the value of interim analyses in clinical trials - PMLiVE
SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days – Consult QD
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial - The Lancet
UCD Clinical Research Centre Annual Report by Advantage Point - Issuu
Randomised clinical trials in critical care: past, present and future | SpringerLink
Free Clinical Trial Templates | Smartsheet
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial - The Lancet
Adaptive designs in clinical trials: why use them, and how to run and report them | BMC Medicine | Full Text
Monitoring Report Template Clinical Trials (1) - TEMPLATES EXAMPLE | TEMPLATES EXAMPLE | Clinical trials, Report template, Clinic
How to develop a Statistical Analysis Plan (SAP) for Clinical Trials
